CPSI Biotech has developed a broad product, technology and intellectual property portfolio covering the Biotech and MedTech spaces for use in the clinical and research science arenas. The CPSI patent portfolio covers a broad range of application areas within the healthcare (clinical) and life science (research) fields. From this portfolio, CPSI Biotech currently has over 10 prototype devices (machines, probes and formulations) in various developmental stages in our active product pipeline.
One focus area for CPSI is Medical Device Development for the treatment of various cancers and cardiovascular disease. CPSI also focuses on the development of new Life Science Technologies for use in the Biotech (research and cell therapy) arenas.
CPSI’s investigative approaches are based on a unique integrated engineering and life sciences strategy designed to identify and modulate stress pathways activated in cells and tissues exposed to stressful environments and utilizing this information as the foundation for the development of new technologies, processes, and protocols. From this strategy, CPSI has developed a unique and diverse portfolio of new technologies representing many potential application areas.
CPSI BIOTECH OFFERS FLEXIBLE INTELLECTUAL PROPERTY (IP) LICENSING PROGRAMS FOR OUR GROWING TECHNOLOGY PORTFOLIO TO LICENSEES WITHIN THE MEDICAL DEVICE INDUSTRY
Various changes within the medical device marketplace, ranging from innovative technology demands, drivers for cost effective treatment options, technology with proven scientific data, regulatory reforms and better solutions to current treatment options can trigger project opportunities. We have and will continue to build our cutting-edge technologies specializing in extreme cold applications as well as providing consultancy help to our customers understand and maximize use of our technology.
With every license, we can offer a comprehensive design package, detailed support to engineering, procurement and manufacturing procedures; extended training; start-up services; and technical assistance. All of our license projects are managed by a dedicated, highly experienced team which draws on the years of experience that has been gained in building and operating cryogenic systems worldwide.
Disclaimer: CPSI Biotech’s technologies are currently Investigational Devices and are limited by Federal Law to Investigational Use Only.